Vulnerable DNA sites make cancer cells sensitive to PARP inhibitors
View as a Web Page
News Medical
 
  Breast Cancer Breast Cancer logo  
  The latest breast cancer news from News Medical  
 Two common forever chemicals linked to higher incidence of ER-negative breast cancerTwo common forever chemicals linked to higher incidence of ER-negative breast cancer
 
Women with higher blood levels of two common per- and polyfluoroalkyl substances, also familiarly known as PFAS, were more likely to develop estrogen receptor-negative, or ER-negative, breast cancer, according to a new study by the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (HHS).
 
 
 Vulnerable DNA sites make cancer cells sensitive to PARP inhibitorsVulnerable DNA sites make cancer cells sensitive to PARP inhibitors
 
A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows.
 
   Chemotherapy may accelerate biological aging in breast cancer survivorsChemotherapy may accelerate biological aging in breast cancer survivors
 
Chemotherapy helps many women survive breast cancer, but new research suggests that chemotherapy may also accelerate biological aging beyond chronological age and increase the risk of earlier death from other causes.
 
   Breakthrough RNA blood test identifies hidden ovarian cancer warning signsBreakthrough RNA blood test identifies hidden ovarian cancer warning signs
 
Hoag researchers announced a first in the world discovery of a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma (STIC), an early, precancerous stage of high-grade serous ovarian cancer (HGSOC).
 
 Single-cell spatial atlas profiles 850,000 cells across breast cancer progression
 
Single-cell spatial atlas profiles 850,000 cells across breast cancer progressionResearchers at The University of Texas MD Anderson Cancer Center have created one of the most detailed maps to date of the cell environment surrounding ductal carcinoma in situ (DCIS), the most common form of preinvasive, or stage 0, breast cancer.
 
 
 Researchers uncover how surrounding cells fuel triple-negative breast cancer growth
 
Researchers uncover how surrounding cells fuel triple-negative breast cancer growthTriple-negative breast cancer, which accounts for approximately 10–15% of all breast cancer cases, is considered particularly difficult to treat because it grows rapidly and carries a high risk of recurrence.
 
 
 Experimental drug targets tumor barriers to unlock cancer-killing T cells
 
Experimental drug targets tumor barriers to unlock cancer-killing T cellsMany solid tumors, including many cancers of the pancreas, breast, brain and lung, protect themselves with a dense wall of scar-like tissue.
 
 
 Women with DCIS may not need routine imaging after double mastectomy
 
Women with DCIS may not need routine imaging after double mastectomyWomen who have undergone a double mastectomy to treat ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer also known as stage 0 breast cancer, may not benefit from routine mammograms or other breast imaging after surgery, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
 
 
 Tai Chi and exercise may improve sleep in older cancer survivors
 
Tai Chi and exercise may improve sleep in older cancer survivorsThere is an hour of the night that belongs to no one. The house has gone still, the furnace has stopped ticking, and a man who beat cancer some years ago lies on his back, counting nothing in particular. He is not alone.
 
 
 Yale Cancer Center offers team-based care for breast cancer patients
 
Yale Cancer Center offers team-based care for breast cancer patientsHilary Axtmayer can pinpoint the moment her life changed. In 2023, Axtmayer-then a 40-year-old mother of two from Madison, Conn.-was receiving her regularly scheduled breast exam when her gynecologist paused mid-palpation. She'd found a lump.
 
 
 Engineered bacteria carrying two anticancer components shrinks aggressive breast cancer in mice
 
Engineered bacteria carrying two anticancer components shrinks aggressive breast cancer in miceTumors that resist immune attack, recur, and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents.
 
 
 Proton therapy radiation patterns may increase breast implant complications
 
Proton therapy radiation patterns may increase breast implant complicationsRadiation therapy is sometimes needed after mastectomy and breast reconstruction for breast cancer.
 
 
 What is fueling the rapid growth of antibody-drug conjugates in biopharma?
 
What is fueling the rapid growth of antibody-drug conjugates in biopharma?Learn how advances in linker technology, payload design, and targeted delivery are driving the next generation of cancer therapies.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney

Copyright © 2000-2026